NWPF

News ArchivesRead News

Your Weekly Parkinson's News Update for the Week of 1.21.19

Monday January 21, 2019
Smart Garments Aim to Stop Falls in People with Parkinson's
Phys.org
"'Existing dopamine therapies offer benefit in treating motor dysfunction in Parkinson's but may not alleviate gait and balance challenges," says Jamie L. Hamilton, Ph.D., Michael J. Fox Foundation (MJFF) Associate Director. 'This project has the potential to become an affordable option to address gait and balance issues and improve overall quality of life for people with Parkinson's.'
Investment from Sensoria Health includes the development of the textile sensor infused Smart Socks with haptic feedback and core microelectronics for the study."
Robotics Research Used in Trials for Parkinson’s Treatments
Compelo
Robotics researchers at Heriot-Watt University in Edinburgh are testing new therapies for Parkinson’s on robots. The study, called “Neurorobotics model of Parkinson’s disease”, will use computer models of the human brain to replace the need for animal testing.
Dr Patricia A Vargas, associate professor of computer science and robotics at Heriot-Watt University, said: “We believe that movement disorders, such as Parkinson’s, result from a disruption in brain-body-environment interactions...Our hope is two-fold – to reduce and replace animals in research, and to help and inform new therapies, treatments and even the cure for this debilitating disease.”
Onstryv Now Approved for Parkinson’s Patients in Canada
Parkinson's News Today
"Onstryv raises the level and function of dopamine in the brain, both through the reversible blockage of the enzyme monoamine oxidase B that normally breaks down this chemical, and by inhibiting transporters responsible for its absorption and retention. In addition, the medicine inhibits the excessive release of the signaling molecule glutamate."
How Gut Bacteria Affect the Treatment of Parkinson's
U.S. News & World Report
"It is well established that gut bacteria can affect the brain," explains Assistant Professor of Microbiology Sahar El Aidy, lead researcher of a new study on gut health and Parkinson's. "There is a continuous chemical dialogue between gut bacteria and the brain, the so-called gut-brain axis." El Aidy and her team investigated the ability of gut microbiota to influence the bioavailability of levodopa in people with Parkinson's.